Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals

06-Jun-2014 - Germany

Dieter Weinand (53), President Global Commercialization & Portfolio Management at Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA, will become President of Bayer HealthCare Pharmaceuticals effective August 1, 2014 and at the same time join the Executive Committee of Bayer HealthCare.

"We welcome Dieter Weinand to our management team. Based on his extensive commercial experience in the pharmaceutical industry, Dieter Weinand will drive the growth of our pharmaceutical business further and maximize the value of our product portfolio," said Olivier Brandicourt, CEO of Bayer HealthCare.

Dieter Weinand has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry. He has been responsible for different markets such as Asia-Pacific, Europe, Middle East, Africa, Latin America and the USA at companies including Pfizer and Bristol-Myers Squibb as well as for the marketing of products in different therapeutic areas such as cardiology, oncology, pulmonology, dermatology, immunology and inflammation.

He will join Bayer HealthCare from Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA, where he is currently responsible as President, Global Commercialization for a $13 billion revenue healthcare business.

Weinand earned a M.S. in Pharmacology/Toxicology from Long Island University, New York, as well as a B.A. in Biology from Concordia College in New York.

Dieter Weinand, who was born in Boppard, Germany, is married and has three children.

https://www.bionity.com/en/news/148613/dieter-weinand-to-become-president-of-bayer-healthcare-pharmaceuticals.html